Maxcyte (MXCT) Gains from Investment Securities (2019 - 2026)
Maxcyte (MXCT) reported Gains from Investment Securities of $625000.0 for Q1 2026, down 82.71% year-over-year from $3.6 million in Q1 2025, and up 1853.12% quarter-over-quarter from $32000.0 in Q4 2025.
Maxcyte (MXCT) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Maxcyte (MXCT) has 8 years of Gains from Investment Securities data on file, last reported at $625000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $625000.0, down 82.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $625000.0 (down 82.71% YoY), and the FY2025 annual result was $8.4 million, up 337.55% from the prior year.
- Gains from Investment Securities improved to $625000.0 in Q1 2026 per MXCT's latest filing, from $32000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $6.4 million in Q2 2023 and troughed at -$410000.0 in Q1 2023.
- A 5-year average of $2.1 million and a median of $855900.0 in 2022 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2023 and 2025: Gains from Investment Securities tumbled 122.89% in 2023, then surged 11053.03% in 2025.
- A 5-year view of Gains from Investment Securities shows it stood at $132763.0 in 2022, then surged by 3135.84% to $4.3 million in 2023, then slumped by 37.85% to $2.7 million in 2024, then tumbled by 98.8% to $32000.0 in 2025, then soared by 1853.12% to $625000.0 in 2026.
- Business Quant data shows MXCT's Gains from Investment Securities at $625000.0 in Q1 2026, $32000.0 in Q4 2025, and $5.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Maxcyte | 120.23 Mn | 120.23 Mn | 8.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 625,000.00 |
| Mar 31, 2026 | 625,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Dec 31, 2025 | 32,000.00 |
| Jun 30, 2025 | 5.44 Mn |
| Jun 30, 2025 | 5.44 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Mar 31, 2025 | 3.61 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Dec 31, 2024 | 2.67 Mn |
| Sep 30, 2024 | 550,838.00 |
| Sep 30, 2024 | 550,838.00 |
| Jun 30, 2024 | 550,838.00 |
| Jun 30, 2024 | 550,838.00 |
| Mar 31, 2024 | -33,000.00 |
| Mar 31, 2024 | -33,000.00 |
| Dec 31, 2023 | 4.30 Mn |
| Dec 31, 2023 | 4.30 Mn |
| Sep 30, 2023 | 6.25 Mn |
| Sep 30, 2023 | 6.25 Mn |